Literature DB >> 18543844

Over-the-counter cough and cold medication use in young children.

Teresa Ryan1, Melanie Brewer, Leigh Small.   

Abstract

During a 2-year period from 2004 and 2005, emergency departments treated over 1,500 children under the age of 2 years for adverse events related to over-the-counter (OTC) cough and cold medication use; these incidents include 3 infant deaths. The risk of overdose, incorrect dosing and adverse events is increased in young children due to the greater number of colds they acquire each year. Lack of evidence to support the use of OTC medications in young children is well documented in the literature; however, people continue to use OTC medications with young children. The common cold is generally a mild, self-limited illness that usually improves with time. Recommended care and treatment for the common cold includes symptomatic treatment. This article presents and reviews the available evidence regarding the use of OTC cough and cold medications for pediatric healthcare providers. This review of the evidence will be helpful for healthcare providers to minimize risks to young children who intentionally or unintentionally ingest these medications and to educate child caregivers regarding proper use of OTC cough and cold medications with children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543844

Source DB:  PubMed          Journal:  Pediatr Nurs        ISSN: 0097-9805


  7 in total

1.  Identifying socio-ecological drivers of common cold in Bhutan: a national surveillance data analysis.

Authors:  Tsheten Tsheten; Kinley Penjor; Chachu Tshering; Archie C A Clements; Darren J Gray; Kinley Wangdi
Journal:  Sci Rep       Date:  2022-07-09       Impact factor: 4.996

2.  Validity of medical history taken by pharmacists using a medical history taking tool.

Authors:  Aya Matsushita; Junji Haruta; Madoka Tsutumi; Takuya Sato; Tetsuhiro Maeno
Journal:  J Gen Fam Med       Date:  2017-06-30

3.  Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity.

Authors:  Theresa Enkirch; Svenja Sauber; Danielle E Anderson; Esther S Gan; Dimitar Kenanov; Sebastian Maurer-Stroh; Veronika von Messling
Journal:  Front Immunol       Date:  2019-06-05       Impact factor: 7.561

Review 4.  Ear, nose and throat manifestation of viral systemic infections in pediatric patients.

Authors:  N Mansi; V de Maio; A della Volpe; G Ripa; L Malafronte; C de Filippis
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2009-12       Impact factor: 1.675

5.  A Review of the Ingredients Contained in Over the Counter (OTC) Cough Syrup Formulations in Kenya. Are They Harmful to Infants?

Authors:  Gabriel Kigen; Naftali Busakhala; Francis Ogaro; Emily Chesire; Nathan Saat; Robert Too; Winstone Nyandiko
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

Review 6.  Drug safety: The concept, inception and its importance in patients' health.

Authors:  Thamir M Alshammari
Journal:  Saudi Pharm J       Date:  2014-05-09       Impact factor: 4.330

7.  A Method for Developing Rapid Screening Values for Active Pharmaceutical Ingredients (APIs) in Water and Results of Initial Application for 119 APIs.

Authors:  Ashley Suchomel; Helen Goeden; Julia Dady
Journal:  Int J Environ Res Public Health       Date:  2018-06-22       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.